{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:27:06Z","timestamp":1794515226272,"version":"4.9.1"},"publisher-location":"Cham","reference-count":251,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319275093","type":"print"},{"value":"9783319275116","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-27511-6_5","type":"book-chapter","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T07:04:24Z","timestamp":1458630264000},"page":"97-131","source":"Crossref","is-referenced-by-count":76,"title":["The TGF-\u03b2 Signalling Network in Muscle Development, Adaptation and Disease"],"prefix":"10.1007","author":[{"given":"Justin L.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Colgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gregorevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,10]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1172\/JCI200420174","volume":"114","author":"S Acharyya","year":"2004","unstructured":"Acharyya S, Ladner KJ, Nelsen LL et al (2004) Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114:370\u2013378","journal-title":"J Clin Invest"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1172\/JCI30556","volume":"117","author":"S Acharyya","year":"2007","unstructured":"Acharyya S, Villalta SA, Bakkar N et al (2007) Interplay of IKK\/NF-kappa B signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117:889\u2013901","journal-title":"J Clin Invest"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst RJ, Hata A (2012) Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 11:790\u2013811","journal-title":"Nat Rev Drug Discov"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jcp.1041330319","volume":"133","author":"RE Allen","year":"1987","unstructured":"Allen RE, Boxhorn LK (1987) Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J Cell Physiol 133:567\u2013572","journal-title":"J Cell Physiol"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"C188","DOI":"10.1152\/ajpcell.00542.2005","volume":"292","author":"DL Allen","year":"2007","unstructured":"Allen DL, Unterman TG (2007) Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 292:C188\u2013C199","journal-title":"Am J Physiol Cell Physiol"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneuroim.2006.03.005","volume":"175","author":"F Andreetta","year":"2006","unstructured":"Andreetta F, Bernasconi P, Baggi F et al (2006) Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy. J Neuroimmunol 175:77\u201386","journal-title":"J Neuroimmunol"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","volume":"361","author":"SD Anker","year":"2003","unstructured":"Anker SD, Negassa A, Coats AJ et al (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361:1077\u20131083","journal-title":"Lancet"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1083\/jcb.200312172","volume":"165","author":"JP Annes","year":"2004","unstructured":"Annes JP, Chen Y, Munger JS et al (2004) Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165:723\u2013734","journal-title":"J Cell Biol"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1152\/japplphysiol.91247.2008","volume":"107","author":"HM Argadine","year":"2009","unstructured":"Argadine HM, Hellyer NJ, Mantilla CB et al (2009) The effect of denervation on protein synthesis and degradation in adult rat diaphragm muscle. J Appl Physiol 107:438\u2013444","journal-title":"J Appl Physiol"},{"key":"5_CR10","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/S0021-9258(18)32345-7","volume":"258","author":"RK Assoian","year":"1983","unstructured":"Assoian RK, Komoriya A, Meyers CA et al (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155\u20137160","journal-title":"J Biol Chem"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mus.23539","volume":"47","author":"KM Attie","year":"2013","unstructured":"Attie KM, Borgstein NG, Yang Y et al (2013) A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve 47:416\u2013423","journal-title":"Muscle Nerve"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B","volume":"67","author":"RL Baldwin","year":"1996","unstructured":"Baldwin RL, Friess H, Yokoyama M et al (1996) Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 67:283\u2013288","journal-title":"Int J Cancer"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2007.04.004","volume":"38","author":"W Baran","year":"2007","unstructured":"Baran W, Szepietowski JC, Mazur G et al (2007) TGF-beta(1) gene polymorphism in psoriasis vulgaris. Cytokine 38:8\u201311","journal-title":"Cytokine"},{"key":"5_CR14","first-page":"8","volume":"3","author":"AP Baumann","year":"2003","unstructured":"Baumann AP, Ibebunjo C, Grasser WA et al (2003) Myostatin expression in age and denervation-induced skeletal muscle atrophy. J Musculoskelet Neuronal Interact 3:8\u201316","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","volume":"66","author":"AR Bauskin","year":"2006","unstructured":"Bauskin AR, Brown DA, Kuffner T et al (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 66:4983\u20134986","journal-title":"Cancer Res"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/jnnp.74.5.633","volume":"74","author":"WM Behan","year":"2003","unstructured":"Behan WM, Longman C, Petty RK et al (2003) Muscle fibrillin deficiency in Marfan\u2019s syndrome myopathy. J Neurol Neurosurg Psychiatry 74:633\u2013638","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/(SICI)1096-8628(19991229)89:4<218::AID-AJMG6>3.0.CO;2-E","volume":"89","author":"C Belville","year":"1999","unstructured":"Belville C, Josso N, Picard JY (1999) Persistence of Mullerian derivatives in males. Am J Med Genet 89:218\u2013223","journal-title":"Am J Med Genet"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1086\/513903","volume":"61","author":"JN Berg","year":"1997","unstructured":"Berg JN, Gallione CJ, Stenzel TT et al (1997) The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61:60\u201367","journal-title":"Am J Hum Genet"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0960-8966(98)00093-5","volume":"9","author":"P Bernasconi","year":"1999","unstructured":"Bernasconi P, Di Blasi C, Mora M et al (1999) Transforming growth factor-beta 1 and fibrosis in congenital muscular dystrophies. Neuromusc Disord 9:28\u201333","journal-title":"Neuromusc Disord"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350\u20131358","journal-title":"N Engl J Med"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Stitt TN, Gonzalez M et al (2001) Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014\u20131019","journal-title":"Nat Cell Biol"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich S, Krag TO, Barton ER et al (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418\u2013421","journal-title":"Nature"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1096\/fj.04-2796com","volume":"19","author":"S Bogdanovich","year":"2005","unstructured":"Bogdanovich S, Perkins KJ, Krag TO et al (2005) Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 19:543\u2013549","journal-title":"FASEB J"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1152\/jappl.1979.47.5.974","volume":"47","author":"FW Booth","year":"1979","unstructured":"Booth FW, Seider MJ (1979) Early change in skeletal muscle protein synthesis after limb immobilization of rats. J Appl Physiol 47:974\u2013977","journal-title":"J Appl Physiol"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286\u20131292","journal-title":"N Engl J Med"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ijc.1332","volume":"93","author":"I Bosaeus","year":"2001","unstructured":"Bosaeus I, Daneryd P, Svanberg E et al (2001) Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93:380\u2013383","journal-title":"Int J Cancer"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1073\/pnas.93.12.5877","volume":"93","author":"EP Bottinger","year":"1996","unstructured":"Bottinger EP, Factor VM, Tsang ML et al (1996) The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci U S A 93:5877\u20135882","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1086\/342067","volume":"71","author":"DJ Brown","year":"2002","unstructured":"Brown DJ, Kim TB, Petty EM et al (2002) Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 71:618\u2013624","journal-title":"Am J Hum Genet"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"13660","DOI":"10.1016\/S0021-9258(18)80047-3","volume":"264","author":"AM Brunner","year":"1989","unstructured":"Brunner AM, Marquardt H, Malacko AR et al (1989) Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264:13660\u201313664","journal-title":"J Biol Chem"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10585-007-9118-2","volume":"24","author":"JT Buijs","year":"2007","unstructured":"Buijs JT, Henriquez NV, Van Overveld PG et al (2007) TGF-beta and BMP7 interactions in tumour progression and bone metastasis. Clin Exp Metastasis 24:609\u2013617","journal-title":"Clin Exp Metastasis"},{"issue":"82","key":"5_CR31","doi-asserted-by":"crossref","first-page":"82ra37","DOI":"10.1126\/scitranslmed.3002227","volume":"3","author":"T. N. Burks","year":"2011","unstructured":"Burks TN, Andres-Mateos E, Marx R et al. (2011) Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med 3:82ra37","journal-title":"Science Translational Medicine"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/338259a0","volume":"338","author":"KP Campbell","year":"1989","unstructured":"Campbell KP, Kahl SD (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338:259\u2013262","journal-title":"Nature"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1474-9726.2009.00517.x","volume":"8","author":"ME Carlson","year":"2009","unstructured":"Carlson ME, Conboy MJ, Hsu M et al (2009) Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell 8:676\u2013689","journal-title":"Aging Cell"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1210\/er.2002-0003","volume":"23","author":"H Chang","year":"2002","unstructured":"Chang H, Brown CW, Matzuk MM (2002) Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 23:787\u2013823","journal-title":"Endocr Rev"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"20533","DOI":"10.1016\/S0021-9258(17)30535-5","volume":"265","author":"S Cheifetz","year":"1990","unstructured":"Cheifetz S, Hernandez H, Laiho M et al (1990) Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 265:20533\u201320538","journal-title":"J Biol Chem"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","volume":"65","author":"YW Chen","year":"2005","unstructured":"Chen YW, Nagaraju K, Bakay M et al (2005) Early onset of inflammation and later involvement of TGF beta in Duchenne muscular dystrophy. Neurology 65:826\u2013834","journal-title":"Neurology"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"11887","DOI":"10.1073\/pnas.1306074110","volume":"110","author":"H Chen","year":"2013","unstructured":"Chen H, Brady Ridgway J, Sai T et al (2013) Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc Natl Acad Sci U S A 110:11887\u201311892","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1096\/fj.13-245894","volume":"28","author":"JL Chen","year":"2014","unstructured":"Chen JL, Walton KL, Winbanks CE et al (2014) Elevated expression of activins promotes muscle wasting and cachexia. FASEB J 28:1711\u20131723","journal-title":"FASEB J"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/mt.2014.221","volume":"23","author":"JL Chen","year":"2015","unstructured":"Chen JL, Walton KL, Al-Musawi SL et al (2015) Development of novel activin-targeted therapeutics. Mol Ther 23:434\u2013444","journal-title":"Mol Ther"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/gerona\/glt030","volume":"68","author":"CS Chiu","year":"2013","unstructured":"Chiu CS, Peekhaus N, Weber H et al (2013) Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents. J Gerontol A Biol Sci Med Sci 68:1181\u20131192","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.biocel.2013.05.016","volume":"45","author":"S Ciciliot","year":"2013","unstructured":"Ciciliot S, Rossi AC, Dyar KA et al (2013) Muscle type and fiber type specificity in muscle wasting. Int J Biochem Cell Biol 45:2191\u20132199","journal-title":"Int J Biochem Cell Biol"},{"key":"5_CR42","first-page":"401","volume":"27","author":"JH Clement","year":"2005","unstructured":"Clement JH, Raida M, Sanger J et al (2005) Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol 27:401\u2013407","journal-title":"Int J Oncol"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T","volume":"23","author":"RD Cohn","year":"2000","unstructured":"Cohn RD, Campbell KP (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23:1456\u20131471","journal-title":"Muscle Nerve"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nm1536","volume":"13","author":"RD Cohn","year":"2007","unstructured":"Cohn RD, Van Erp C, Habashi JP et al (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13:204\u2013210","journal-title":"Nat Med"},{"issue":"9","key":"5_CR45","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/gerona\/glt170","volume":"69","author":"H. Collins-Hooper","year":"2014","unstructured":"Collins-Hooper H, Sartori R, Macharia R et al. (2014) Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice. J Gerontol A Biol Sci Med Sci 69(9):1049\u20131059","journal-title":"The Journals of Gerontology Series A: Biological Sciences and Medical Sciences"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bbamem.2013.08.023","volume":"1838","author":"B Constantin","year":"2014","unstructured":"Constantin B (2014) Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta-Biomembr 1838:635\u2013642","journal-title":"Biochim Biophys Acta-Biomembr"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1006\/dbio.2000.9682","volume":"224","author":"DD Cornelison","year":"2000","unstructured":"Cornelison DD, Olwin BB, Rudnicki MA et al (2000) MyoD(-\/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev Biol 224:122\u2013137","journal-title":"Dev Biol"},{"key":"5_CR48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1242\/dev.120.4.925","volume":"120","author":"MG Cusella-De Angelis","year":"1994","unstructured":"Cusella-De Angelis MG, Molinari S, Le Donne A et al (1994) Differential response of embryonic and fetal myoblasts to TGF beta: a possible regulatory mechanism of skeletal muscle histogenesis. Development 120:925\u2013933","journal-title":"Development"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1210\/jcem.84.5.5704","volume":"84","author":"FH D\u2019abronzo","year":"1999","unstructured":"D\u2019abronzo FH, Swearingen B, Klibanski A et al (1999) Mutational analysis of activin\/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors. J Clin Endocrinol Metab 84:1716\u20131721","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/gerona\/glu013","volume":"69","author":"TT Dam","year":"2014","unstructured":"Dam TT, Peters KW, Fragala M et al (2014) An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 69:584\u2013590","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1113\/jphysiol.2007.142828","volume":"585","author":"MD Boer De","year":"2007","unstructured":"De Boer MD, Selby A, Atherton P et al (2007) The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol 585:241\u2013251","journal-title":"J Physiol"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"29632","DOI":"10.1074\/jbc.M009765200","volume":"276","author":"G Crescenzo De","year":"2001","unstructured":"De Crescenzo G, Grothe S, Zwaagstra J et al (2001) Real-time monitoring of the interactions of transforming growth factor-beta (TGF-beta) isoforms with latency-associated protein and the ectodomains of the TGF-beta type II and III receptors reveals different kinetic models and stoichiometries of binding. J Biol Chem 276:29632\u201329643","journal-title":"J Biol Chem"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/sj.ejhg.5201851","volume":"15","author":"JC Dean","year":"2007","unstructured":"Dean JC (2007) Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 15:724\u2013733","journal-title":"Eur J Hum Genet"},{"key":"5_CR54","first-page":"251","volume":"5","author":"WD Dewys","year":"1986","unstructured":"Dewys WD (1986) Weight-loss and nutritional abnormalities in cancer-patients \u2013 incidence, severity and significance. Clin Oncol 5:251\u2013261","journal-title":"Clin Oncol"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan-syndrome caused by a recurrent denovo missense mutation in the fibrillin gene. Nature 352:337\u2013339","journal-title":"Nature"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"10618","DOI":"10.1074\/jbc.270.18.10618","volume":"270","author":"CM Dubois","year":"1995","unstructured":"Dubois CM, Laprise MH, Blanchette F et al (1995) Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270:10618\u201310624","journal-title":"J Biol Chem"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1096\/fj.02-1215rev","volume":"17","author":"E Engvall","year":"2003","unstructured":"Engvall E, Wewer UM (2003) The new frontier in muscular dystrophy research: booster genes. FASEB J 17:1579\u20131584","journal-title":"FASEB J"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0092-8674(00)80128-2","volume":"86","author":"K Eppert","year":"1996","unstructured":"Eppert K, Scherer SW, Ozcelik H et al (1996) MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543\u2013552","journal-title":"Cell"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti JM, Ohlendieck K, Kahl SD et al (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315\u2013319","journal-title":"Nature"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10:90\u201399","journal-title":"Nat Rev Clin Oncol"},{"key":"5_CR61","doi-asserted-by":"crossref","unstructured":"Franken R, Radonic T, Den Hartog AW et al (2014) The revised role of TGF-beta in aortic aneurysms in Marfan syndrome. Neth Heart J","DOI":"10.1007\/s12471-014-0622-0"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11154-006-9000-6","volume":"7","author":"E Gazzerro","year":"2006","unstructured":"Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51\u201365","journal-title":"Rev Endocr Metab Disord"},{"key":"5_CR63","doi-asserted-by":"crossref","first-page":"A515","DOI":"10.1096\/fj.05-4873fje","volume":"20","author":"GX Ge","year":"2006","unstructured":"Ge GX, Hopkins DR, Greenspan DS (2006) GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. FASEB J 20:A515","journal-title":"FASEB J"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1021\/bi00481a014","volume":"29","author":"LE Gentry","year":"1990","unstructured":"Gentry LE, Nash BW (1990) The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 29:6851\u20136857","journal-title":"Biochemistry"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1128\/MCB.8.10.4162","volume":"8","author":"LE Gentry","year":"1988","unstructured":"Gentry LE, Lioubin MN, Purchio AF et al (1988) Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 8:4162\u20134168","journal-title":"Mol Cell Biol"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.2010.05809.x","volume":"1211","author":"D Glass","year":"2010","unstructured":"Glass D, Roubenoff R (2010) Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci 1211:25\u201336","journal-title":"Ann N Y Acad Sci"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1530\/rep.1.00090","volume":"127","author":"C Glister","year":"2004","unstructured":"Glister C, Kemp CF, Knight PG (2004) Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127:239\u2013254","journal-title":"Reproduction"},{"key":"5_CR68","first-page":"5329","volume":"58","author":"M Goggins","year":"1998","unstructured":"Goggins M, Shekher M, Turnacioglu K et al (1998) Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 58:5329\u20135332","journal-title":"Cancer Res"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/6821","volume":"21","author":"Y Gong","year":"1999","unstructured":"Gong Y, Krakow D, Marcelino J et al (1999) Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21:302\u2013304","journal-title":"Nat Genet"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","volume":"1782","author":"KJ Gordon","year":"2008","unstructured":"Gordon KJ, Blobe GC (2008) Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 1782:197\u2013228","journal-title":"Biochim Biophys Acta"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/mus.20056","volume":"30","author":"LE Gosselin","year":"2004","unstructured":"Gosselin LE, Martinez DA (2004) Impact of TNF-alpha blockade on TGF-beta 1 and type I collagen mRNA expression in dystrophic muscle. Muscle Nerve 30:244\u2013246","journal-title":"Muscle Nerve"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/mus.20150","volume":"30","author":"LE Gosselin","year":"2004","unstructured":"Gosselin LE, Williams JE, Deering M et al (2004) Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle. Muscle Nerve 30:645\u2013653","journal-title":"Muscle Nerve"},{"key":"5_CR73","first-page":"320","volume":"59","author":"WM Grady","year":"1999","unstructured":"Grady WM, Myeroff LL, Swinler SE et al (1999) Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 59:320\u2013324","journal-title":"Cancer Res"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1097-2765(03)00094-7","volume":"11","author":"J Greenwald","year":"2003","unstructured":"Greenwald J, Groppe J, Gray P et al (2003) The BMP7\/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11:605\u2013617","journal-title":"Mol Cell"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","volume":"34","author":"M Groenink","year":"2013","unstructured":"Groenink M, Den Hartog AW, Franken R et al (2013) Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 34:3491\u20133500","journal-title":"Eur Heart J"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/BLO.0b013e318126c049","volume":"462","author":"JC Groppe","year":"2007","unstructured":"Groppe JC, Shore EM, Kaplan FS (2007) Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res 462:87\u201392","journal-title":"Clin Orthop Relat Res"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117\u2013121","journal-title":"Science"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn SA, Schutte M, Hoque AT et al (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350\u2013353","journal-title":"Science"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1593\/neo.04640","volume":"7","author":"SK Halder","year":"2005","unstructured":"Halder SK, Beauchamp RD, Datta PK (2005) A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 7:509\u2013521","journal-title":"Neoplasia"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"27161","DOI":"10.1074\/jbc.274.38.27161","volume":"274","author":"H Hanafusa","year":"1999","unstructured":"Hanafusa H, Ninomiya-Tsuji J, Masuyama N et al (1999) Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 274:27161\u201327167","journal-title":"J Biol Chem"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/sj.emboj.7601000","volume":"25","author":"AE Harrington","year":"2006","unstructured":"Harrington AE, Morris-Triggs SA, Ruotolo BT et al (2006) Structural basis for the inhibition of activin signalling by follistatin. EMBO J 25:1035\u20131045","journal-title":"EMBO J"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"28036","DOI":"10.1074\/jbc.M402782200","volume":"279","author":"CA Harrison","year":"2004","unstructured":"Harrison CA, Gray PC, Fischer WH et al (2004) An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors. J Biol Chem 279:28036\u201328044","journal-title":"J Biol Chem"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/08977194.2011.608666","volume":"29","author":"CA Harrison","year":"2011","unstructured":"Harrison CA, Al-Musawi SL, Walton KL (2011) Prodomains regulate the synthesis, extracellular localisation and activity of TGF-beta superfamily ligands. Growth Factors 29:174\u2013186","journal-title":"Growth Factors"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"40735","DOI":"10.1074\/jbc.M206379200","volume":"277","author":"JJ Hill","year":"2002","unstructured":"Hill JJ, Davies MV, Pearson AA et al (2002) The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277:40735\u201340741","journal-title":"J Biol Chem"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/clc.22320","volume":"37","author":"M Hillebrand","year":"2014","unstructured":"Hillebrand M, Millot N, Sheikhzadeh S et al (2014) Total serum transforming growth factor-beta 1 is elevated in the entire spectrum of genetic aortic syndromes. Clin Cardiol 37:672\u2013679","journal-title":"Clin Cardiol"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin \u2013 the protein product of the duchenne muscular-dystrophy locus. Cell 51:919\u2013928","journal-title":"Cell"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1056\/NEJM199007193230303","volume":"323","author":"DW Hollister","year":"1990","unstructured":"Hollister DW, Godfrey M, Sakai LY et al (1990) Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan-syndrome. N Engl J Med 323:152\u2013159","journal-title":"N Engl J Med"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.280.5366.1086","volume":"280","author":"JR Howe","year":"1998","unstructured":"Howe JR, Roth S, Ringold JC et al (1998) Mutations in the SMAD4\/DPC4 gene in juvenile polyposis. Science 280:1086\u20131088","journal-title":"Science"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/88919","volume":"28","author":"JR Howe","year":"2001","unstructured":"Howe JR, Bair JL, Sayed MG et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184\u2013187","journal-title":"Nat Genet"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1083\/jcb.200212107","volume":"162","author":"ML Hribal","year":"2003","unstructured":"Hribal ML, Nakae J, Kitamura T et al (2003) Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol 162:535\u2013541","journal-title":"J Cell Biol"},{"key":"5_CR91","doi-asserted-by":"crossref","first-page":"19380","DOI":"10.1016\/S0021-9258(17)32179-8","volume":"269","author":"P Husken-Hindi","year":"1994","unstructured":"Husken-Hindi P, Tsuchida K, Park M et al (1994) Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. J Biol Chem 269:19380\u201319384","journal-title":"J Biol Chem"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10:415\u2013424","journal-title":"Nat Rev Cancer"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000351462","volume":"198","author":"S Iwasaki","year":"2013","unstructured":"Iwasaki S, Miyak M, Hayashi S et al (2013) Effect of myostatin on chemokine expression in regenerating skeletal muscle cells. Cells Tissues Organs 198:66\u201374","journal-title":"Cells Tissues Organs"},{"key":"5_CR94","first-page":"312","volume":"15","author":"S Iwase","year":"2004","unstructured":"Iwase S, Murakami T, Saito Y et al (2004) Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients. Eur Cytokine Netw 15:312\u2013316","journal-title":"Eur Cytokine Netw"},{"key":"5_CR95","first-page":"513","volume":"33","author":"PA Jacobs","year":"1981","unstructured":"Jacobs PA, Hunt PA, Mayer M et al (1981) Duchenne muscular-dystrophy (DMD) in a female with an X-autosome translocation \u2013 further evidence that the dmd locus is at Xp21. Am J Hum Genet 33:513\u2013518","journal-title":"Am J Hum Genet"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1038\/sj.onc.1208928","volume":"24","author":"D Javelaud","year":"2005","unstructured":"Javelaud D, Mauviel A (2005) Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 24:5742\u20135750","journal-title":"Oncogene"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1600-0838.2005.00498.x","volume":"16","author":"J Jespersen","year":"2006","unstructured":"Jespersen J, Kjaer M, Schjerling P (2006) The possible role of myostatin in skeletal muscle atrophy and cachexia. Scand J Med Sci Sports 16:74\u201382","journal-title":"Scand J Med Sci Sports"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1242\/dmm.015917","volume":"7","author":"CH Jiang","year":"2014","unstructured":"Jiang CH, Wen YF, Kuroda K et al (2014) Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy. Dis Model Mech 7:997\u20131004","journal-title":"Dis Model Mech"},{"key":"5_CR99","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1096\/fj.03-1228fje","volume":"18","author":"SW Jones","year":"2004","unstructured":"Jones SW, Hill RJ, Krasney PA et al (2004) Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 18:1025\u20131027","journal-title":"FASEB J"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.yexcr.2006.07.010","volume":"312","author":"D Joulia-Ekaza","year":"2006","unstructured":"Joulia-Ekaza D, Cabello G (2006) Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. Exp Cell Res 312:2401\u20132414","journal-title":"Exp Cell Res"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","volume":"366","author":"DP Judge","year":"2005","unstructured":"Judge DP, Dietz HC (2005) Marfan\u2019s syndrome. Lancet 366:1965\u20131976","journal-title":"Lancet"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/ALN.0000000000000201","volume":"120","author":"B Jung","year":"2014","unstructured":"Jung B, Nougaret S, Conseil M et al (2014) Sepsis is associated with a preferential diaphragmatic atrophy a critically Ill patient study using tridimensional computed tomography. Anesthesiology 120:1182\u20131191","journal-title":"Anesthesiology"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng0303-331","volume":"33","author":"V Kaartinen","year":"2003","unstructured":"Kaartinen V, Warburton D (2003) Fibrillin controls TGF-beta activation. Nat Genet 33:331\u2013332","journal-title":"Nat Genet"},{"key":"5_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/79128","volume":"26","author":"A Kinoshita","year":"2000","unstructured":"Kinoshita A, Saito T, Tomita H et al (2000) Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 26:19\u201320","journal-title":"Nat Genet"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1128\/MCB.16.7.3480","volume":"16","author":"PI Knaus","year":"1996","unstructured":"Knaus PI, Lindemann D, Decoteau JF et al (1996) A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 16:3480\u20133489","journal-title":"Mol Cell Biol"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","volume":"50","author":"M Koenig","year":"1987","unstructured":"Koenig M, Hoffman EP, Bertelson CJ et al (1987) Complete cloning of the Duchenne muscular-dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509\u2013517","journal-title":"Cell"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1152\/japplphysiol.01091.2007","volume":"104","author":"HD Kollias","year":"2008","unstructured":"Kollias HD, Mcdermott JC (2008) Transforming growth factor-beta and myostatin signaling in skeletal muscle. J Appl Physiol 104:579\u2013587","journal-title":"J Appl Physiol"},{"key":"5_CR108","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/0006-291X(89)90837-1","volume":"162","author":"T Kubota","year":"1989","unstructured":"Kubota T, Zhang Q, Wrana JL et al (1989) Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta. Biochem Biophys Res Commun 162:1453\u20131459","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR109","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urology.2006.09.039","volume":"69","author":"K Kuroda","year":"2007","unstructured":"Kuroda K, Nakashima J, Kanao K et al (2007) Interleukin 6 is associated with cachexia in patients with prostate cancer. Urology 69:113\u2013117","journal-title":"Urology"},{"key":"5_CR110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1042\/bst0240054","volume":"24","author":"NB Thangue La","year":"1996","unstructured":"La Thangue NB (1996) E2F and the molecular mechanisms of early cell-cycle control. Biochem Soc Trans 24:54\u201359","journal-title":"Biochem Soc Trans"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/MCB.01307-13","volume":"34","author":"E Lach-Trifilieff","year":"2014","unstructured":"Lach-Trifilieff E, Minetti GC, Sheppard K et al (2014) An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol 34:606\u2013618","journal-title":"Mol Cell Biol"},{"key":"5_CR112","doi-asserted-by":"crossref","unstructured":"Lacro RV, Guey LT, Dietz HC et al. (2013) Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and Losartan therapy. Am Heart J 165:828\u2013835","DOI":"10.1016\/j.ahj.2013.02.019"},{"key":"5_CR113","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro RV, Dietz HC, Sleeper LA et al (2014) Atenolol versus Losartan in children and young adults with Marfan\u2019s syndrome. N Engl J Med 371:2061\u20132071","journal-title":"N Engl J Med"},{"key":"5_CR114","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0955-0674(94)90057-4","volume":"6","author":"EW Lam","year":"1994","unstructured":"Lam EW, La Thangue NB (1994) DP and E2F proteins: coordinating transcription with cell cycle progression. Curr Opin Cell Biol 6:859\u2013866","journal-title":"Curr Opin Cell Biol"},{"key":"5_CR115","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","volume":"26","author":"KB Lane","year":"2000","unstructured":"Lane KB, Machado RD, Pauciulo MW et al (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26:81\u201384","journal-title":"Nat Genet"},{"key":"5_CR116","doi-asserted-by":"publisher","first-page":"49831","DOI":"10.1074\/jbc.M204291200","volume":"277","author":"B Langley","year":"2002","unstructured":"Langley B, Thomas M, Bishop A et al (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277:49831\u201349840","journal-title":"J Biol Chem"},{"key":"5_CR117","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1124\/mol.62.1.58","volume":"62","author":"NJ Laping","year":"2002","unstructured":"Laping NJ, Grygielko E, Mathur A et al (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62:58\u201364","journal-title":"Mol Pharmacol"},{"key":"5_CR118","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293","journal-title":"Cell"},{"key":"5_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000789","volume":"2","author":"SJ Lee","year":"2007","unstructured":"Lee SJ (2007) Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One 2, e789","journal-title":"PLoS One"},{"key":"5_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001628","volume":"3","author":"SJ Lee","year":"2008","unstructured":"Lee SJ (2008) Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One 3, e1628","journal-title":"PLoS One"},{"key":"5_CR121","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"SJ Lee","year":"2001","unstructured":"Lee SJ, Mcpherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98:9306\u20139311","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR122","doi-asserted-by":"publisher","first-page":"18117","DOI":"10.1073\/pnas.0505996102","volume":"102","author":"SJ Lee","year":"2005","unstructured":"Lee SJ, Reed LA, Davies MV et al (2005) Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A 102:18117\u201318122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR123","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/rej.2007.0588","volume":"11","author":"B Leger","year":"2008","unstructured":"Leger B, Derave W, De Bock K et al (2008) Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of akt phosphorylation. Rejuvenation Res 11:163\u2013175","journal-title":"Rejuvenation Res"},{"key":"5_CR124","doi-asserted-by":"publisher","first-page":"12277","DOI":"10.1073\/pnas.2133476100","volume":"100","author":"K Lehmann","year":"2003","unstructured":"Lehmann K, Seemann P, Stricker S et al (2003) Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc Natl Acad Sci U S A 100:12277\u201312282","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR125","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1086\/519697","volume":"81","author":"K Lehmann","year":"2007","unstructured":"Lehmann K, Seemann P, Silan F et al (2007) A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet 81:388\u2013396","journal-title":"Am J Hum Genet"},{"key":"5_CR126","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/35006129","volume":"404","author":"KA Lewis","year":"2000","unstructured":"Lewis KA, Gray PC, Blount AL et al (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404:411\u2013414","journal-title":"Nature"},{"key":"5_CR127","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/01.HYP.33.1.271","volume":"33","author":"B Li","year":"1999","unstructured":"Li B, Khanna A, Sharma V et al (1999) TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 33:271\u2013275","journal-title":"Hypertension"},{"key":"5_CR128","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0002-9440(10)63188-4","volume":"164","author":"Y Li","year":"2004","unstructured":"Li Y, Foster W, Deasy BM et al (2004) Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 164:1007\u20131019","journal-title":"Am J Pathol"},{"key":"5_CR129","doi-asserted-by":"publisher","first-page":"36645","DOI":"10.1074\/jbc.M110.177865","volume":"285","author":"S Li","year":"2010","unstructured":"Li S, Shimono C, Norioka N et al (2010) Activin A binds to perlecan through its pro-region that has heparin\/heparan sulfate binding activity. J Biol Chem 285:36645\u201336655","journal-title":"J Biol Chem"},{"key":"5_CR130","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.febslet.2010.04.039","volume":"584","author":"C Lipina","year":"2010","unstructured":"Lipina C, Kendall H, Mcpherron AC et al (2010) Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice. FEBS Lett 584:2403\u20132408","journal-title":"FEBS Lett"},{"key":"5_CR131","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1101\/gad.925901","volume":"15","author":"D Liu","year":"2001","unstructured":"Liu D, Black BL, Derynck R (2001) TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 15:2950\u20132966","journal-title":"Genes Dev"},{"key":"5_CR132","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys BL, Chen J, Neptune ER et al (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275\u2013281","journal-title":"Nat Genet"},{"key":"5_CR133","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1210\/me.2011-1124","volume":"25","author":"S Lokireddy","year":"2011","unstructured":"Lokireddy S, Mcfarlane C, Ge X et al (2011) Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Mol Endocrinol 25:1936\u20131949","journal-title":"Mol Endocrinol"},{"key":"5_CR134","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/BJ20112024","volume":"446","author":"S Lokireddy","year":"2012","unstructured":"Lokireddy S, Wijesoma IW, Bonala S et al (2012) Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem J 446:23\u201336","journal-title":"Biochem J"},{"key":"5_CR135","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1056\/NEJM200108023450511","volume":"345","author":"J Loscalzo","year":"2001","unstructured":"Loscalzo J (2001) Genetic clues to the cause of primary pulmonary hypertension. N Engl J Med 345:367\u2013371","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"5_CR136","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2106\/00004623-200300003-00008","volume":"85-A","author":"K Luo","year":"2003","unstructured":"Luo K (2003) Negative regulation of BMP signaling by the ski oncoprotein. J Bone Joint Surg Am 85-A(Suppl 3):39\u201343","journal-title":"J Bone Joint Surg Am"},{"key":"5_CR137","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.1999.17.2.607","volume":"17","author":"Y Maehara","year":"1999","unstructured":"Maehara Y, Kakeji Y, Kabashima A et al (1999) Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 17:607\u2013614","journal-title":"J Clin Oncol"},{"key":"5_CR138","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","volume":"6","author":"J Massague","year":"1990","unstructured":"Massague J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6:597\u2013641","journal-title":"Annu Rev Cell Biol"},{"key":"5_CR139","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massague","year":"1998","unstructured":"Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753\u2013791","journal-title":"Annu Rev Biochem"},{"key":"5_CR140","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.febslet.2006.04.033","volume":"580","author":"J Massague","year":"2006","unstructured":"Massague J, Gomis RR (2006) The logic of TGFbeta signaling. FEBS Lett 580:2811\u20132820","journal-title":"FEBS Lett"},{"key":"5_CR141","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.1073\/pnas.83.21.8206","volume":"83","author":"J Massague","year":"1986","unstructured":"Massague J, Cheifetz S, Endo T et al (1986) Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A 83:8206\u20138210","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR142","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/humu.20353","volume":"27","author":"G Matyas","year":"2006","unstructured":"Matyas G, Arnold E, Carrel T et al (2006) Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat 27:760\u2013769","journal-title":"Hum Mutat"},{"key":"5_CR143","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/360313a0","volume":"360","author":"MM Matzuk","year":"1992","unstructured":"Matzuk MM, Finegold MJ, Su JG et al (1992) Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313\u2013319","journal-title":"Nature"},{"key":"5_CR144","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","volume":"91","author":"MM Matzuk","year":"1994","unstructured":"Matzuk MM, Finegold MJ, Mather JP et al (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A 91:8817\u20138821","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5_CR145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.9.2.493","volume":"9","author":"A. Mauro","year":"1961","unstructured":"Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493\u2013495","journal-title":"The Journal of Cell Biology"},{"key":"5_CR146","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA Mcallister","year":"1994","unstructured":"Mcallister KA, Grogg KM, Johnson DW et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345\u2013351","journal-title":"Nat Genet"},{"key":"5_CR147","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1172\/JCI119754","volume":"100","author":"TA Mccaffrey","year":"1997","unstructured":"Mccaffrey TA, Du B, Consigli S et al (1997) Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 100:2182\u20132188","journal-title":"J Clin Invest"},{"key":"5_CR148","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1083\/jcb.200207056","volume":"162","author":"S Mccroskery","year":"2003","unstructured":"Mccroskery S, Thomas M, Maxwell L et al (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135\u20131147","journal-title":"J Cell Biol"},{"key":"5_CR149","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC Mcpherron","year":"1997","unstructured":"Mcpherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83\u201390","journal-title":"Nature"},{"key":"5_CR150","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1101\/gad.10.10.1173","volume":"10","author":"LA Megeney","year":"1996","unstructured":"Megeney LA, Kablar B, Garrett K et al (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10:1173\u20131183","journal-title":"Genes Dev"},{"key":"5_CR151","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/mt.2014.200","volume":"23","author":"JR Mendell","year":"2015","unstructured":"Mendell JR, Sahenk Z, Malik V et al (2015) A phase 1\/2a follistatin gene therapy trial for Becker muscular dystrophy. Mol Ther 23:192\u2013201","journal-title":"Mol Ther"},{"key":"5_CR152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/01635581.2015.976318","volume":"67","author":"P Mondello","year":"2015","unstructured":"Mondello P, Mian M, Aloisi C et al (2015) Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options. Nutr Cancer 67:12\u201326","journal-title":"Nutr Cancer"},{"key":"5_CR153","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/mus.21743","volume":"42","author":"KJ Morine","year":"2010","unstructured":"Morine KJ, Bish LT, Selsby JT et al (2010) Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy. Muscle Nerve 42:722\u2013730","journal-title":"Muscle Nerve"},{"key":"5_CR154","doi-asserted-by":"publisher","first-page":"C1124","DOI":"10.1152\/ajpcell.00043.2009","volume":"297","author":"MR Morissette","year":"2009","unstructured":"Morissette MR, Cook SA, Buranasombati C et al (2009) Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. Am J Physiol Cell Physiol 297:C1124\u2013C1132","journal-title":"Am J Physiol Cell Physiol"},{"key":"5_CR155","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","volume":"83","author":"JE Morley","year":"2006","unstructured":"Morley JE, Thomas DR, Wilson MM (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735\u2013743","journal-title":"Am J Clin Nutr"},{"key":"5_CR156","first-page":"1091","volume":"21","author":"AG Moses","year":"2009","unstructured":"Moses AG, Maingay J, Sangster K et al (2009) Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 21:1091\u20131095","journal-title":"Oncol Rep"},{"key":"5_CR157","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1359-6101(99)00026-X","volume":"11","author":"KM Mulder","year":"2000","unstructured":"Mulder KM (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11:23\u201335","journal-title":"Cytokine Growth Factor Rev"},{"key":"5_CR158","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1096\/fj.10-159608","volume":"24","author":"KT Murphy","year":"2010","unstructured":"Murphy KT, Koopman R, Naim T et al (2010) Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J 24:4433\u20134442","journal-title":"FASEB J"},{"key":"5_CR159","doi-asserted-by":"publisher","first-page":"R716","DOI":"10.1152\/ajpregu.00121.2011","volume":"301","author":"KT Murphy","year":"2011","unstructured":"Murphy KT, Chee A, Gleeson BG et al (2011) Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am J Physiol Regul Integr Comp Physiol 301:R716\u2013R726","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5_CR160","first-page":"5545","volume":"55","author":"LL Myeroff","year":"1995","unstructured":"Myeroff LL, Parsons R, Kim SJ et al (1995) A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545\u20135547","journal-title":"Cancer Res"},{"key":"5_CR161","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1126\/science.2106159","volume":"247","author":"T Nakamura","year":"1990","unstructured":"Nakamura T, Takio K, Eto Y et al (1990) Activin-binding protein from rat ovary is follistatin. Science 247:836\u2013838","journal-title":"Science"},{"key":"5_CR162","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune ER, Frischmeyer PA, Arking DE et al (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407\u2013411","journal-title":"Nat Genet"},{"key":"5_CR163","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1172\/JCI200422715","volume":"114","author":"CM Ng","year":"2004","unstructured":"Ng CM, Cheng A, Myers LA et al (2004) TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114:1586\u20131592","journal-title":"J Clin Invest"},{"key":"5_CR164","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","volume":"50","author":"A Oliff","year":"1987","unstructured":"Oliff A, Defeo-Jones D, Boyer M et al (1987) Tumors secreting human TNF\/cachectin induce cachexia in mice. Cell 50:555\u2013563","journal-title":"Cell"},{"key":"5_CR165","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1083\/jcb.103.5.1799","volume":"103","author":"EN Olson","year":"1986","unstructured":"Olson EN, Sternberg E, Hu JS et al (1986) Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol 103:1799\u20131805","journal-title":"J Cell Biol"},{"key":"5_CR166","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1196\/annals.1383.024","volume":"1085","author":"H Pannu","year":"2006","unstructured":"Pannu H, Avidan N, Tran-Fadulu V et al (2006) Genetic basis of thoracic aortic aneurysms and dissections: potential relevance to abdominal aortic aneurysms. Ann N Y Acad Sci 1085:242\u2013255","journal-title":"Ann N Y Acad Sci"},{"key":"5_CR167","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.amjcard.2013.06.019","volume":"112","author":"C Pees","year":"2013","unstructured":"Pees C, Laccone F, Hagl M et al (2013) Usefulness of Losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome. Am J Cardiol 112:1477\u20131483","journal-title":"Am J Cardiol"},{"key":"5_CR168","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cellsig.2004.08.003","volume":"17","author":"B Philip","year":"2005","unstructured":"Philip B, Lu Z, Gao Y (2005) Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal 17:365\u2013375","journal-title":"Cell Signal"},{"key":"5_CR169","first-page":"150","volume":"24","author":"M Pirisi","year":"2000","unstructured":"Pirisi M, Fabris C, Luisi S et al (2000) Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. Cancer Detect Prev 24:150\u2013155","journal-title":"Cancer Detect Prev"},{"key":"5_CR170","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ajpath.2010.11.071","volume":"178","author":"EE Pistilli","year":"2011","unstructured":"Pistilli EE, Bogdanovich S, Goncalves MD et al (2011) Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy. Am J Pathol 178:1287\u20131297","journal-title":"Am J Pathol"},{"key":"5_CR171","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.2013.278481","volume":"310","author":"ZA Puthucheary","year":"2013","unstructured":"Puthucheary ZA, Rawal J, Mcphail M et al (2013) Acute skeletal muscle wasting in critical illness. JAMA 310:1591\u20131600","journal-title":"JAMA"},{"key":"5_CR172","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/jcb.21501","volume":"102","author":"RA Rahimi","year":"2007","unstructured":"Rahimi RA, Leof EB (2007) TGF-beta signaling: a tale of two responses. J Cell Biochem 102:593\u2013608","journal-title":"J Cell Biochem"},{"key":"5_CR173","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.gde.2007.04.006","volume":"17","author":"F Ramirez","year":"2007","unstructured":"Ramirez F, Dietz HC (2007) Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 17:252\u2013258","journal-title":"Curr Opin Genet Dev"},{"key":"5_CR174","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ceb.2009.05.005","volume":"21","author":"F Ramirez","year":"2009","unstructured":"Ramirez F, Rifkin DB (2009) Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr Opin Cell Biol 21:616\u2013622","journal-title":"Curr Opin Cell Biol"},{"key":"5_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03008200701820708","volume":"49","author":"F Ramirez","year":"2008","unstructured":"Ramirez F, Carta L, Lee-Arteaga S et al (2008) Fibrillin-rich microfibrils \u2013 structural and instructive determinants of mammalian development and physiology. Connect Tissue Res 49:1\u20136","journal-title":"Connect Tissue Res"},{"key":"5_CR176","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/mus.1086","volume":"24","author":"KA Reardon","year":"2001","unstructured":"Reardon KA, Davis J, Kapsa RM et al (2001) Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 24:893\u2013899","journal-title":"Muscle Nerve"},{"key":"5_CR177","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1074\/jbc.272.2.1231","volume":"272","author":"DP Reinhardt","year":"1997","unstructured":"Reinhardt DP, Ono RN, Sakai LY (1997) Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem 272:1231\u20131236","journal-title":"J Biol Chem"},{"key":"5_CR178","doi-asserted-by":"publisher","first-page":"13586","DOI":"10.1074\/jbc.274.19.13586","volume":"274","author":"SM Ribeiro","year":"1999","unstructured":"Ribeiro SM, Poczatek M, Schultz-Cherry S et al (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274:13586\u201313593","journal-title":"J Biol Chem"},{"key":"5_CR179","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1074\/jbc.R400029200","volume":"280","author":"DB Rifkin","year":"2005","unstructured":"Rifkin DB (2005) Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 280:7409\u20137412","journal-title":"J Biol Chem"},{"key":"5_CR180","first-page":"2578","volume":"57","author":"GJ Riggins","year":"1997","unstructured":"Riggins GJ, Kinzler KW, Vogelstein B et al (1997) Frequency of Smad gene mutations in human cancers. Cancer Res 57:2578\u20132580","journal-title":"Cancer Res"},{"key":"5_CR181","doi-asserted-by":"publisher","first-page":"C993","DOI":"10.1152\/ajpcell.00372.2001","volume":"282","author":"R Rios","year":"2002","unstructured":"Rios R, Carneiro I, Arce VM et al (2002) Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282:C993\u2013C999","journal-title":"Am J Physiol Cell Physiol"},{"key":"5_CR182","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.21244","volume":"39","author":"LR Rodino-Klapac","year":"2009","unstructured":"Rodino-Klapac LR, Haidet AM, Kota J et al (2009) Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 39:283\u2013296","journal-title":"Muscle Nerve"},{"issue":"Suppl 3","key":"5_CR183","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1038\/sj.ejcn.1601024","volume":"54","author":"R Roubenoff","year":"2000","unstructured":"Roubenoff R (2000) Sarcopenia and its implications for the elderly. Eur J Clin Nutr 54(Suppl 3):S40\u2013S47","journal-title":"Eur J Clin Nutr"},{"key":"5_CR184","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.matbio.2011.12.003","volume":"31","author":"P Sabatelli","year":"2012","unstructured":"Sabatelli P, Gualandi F, Gara SK et al (2012) Expression of collagen VI alpha 5 and alpha 6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis. Matrix Biol 31:187\u2013196","journal-title":"Matrix Biol"},{"key":"5_CR185","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1164\/rccm.200704-561OC","volume":"176","author":"MT Salam","year":"2007","unstructured":"Salam MT, Gauderman WJ, Mcconnell R et al (2007) Transforming growth factor- 1 C-509 T polymorphism, oxidant stress, and early-onset childhood asthma. Am J Respir Crit Care Med 176:1192\u20131199","journal-title":"Am J Respir Crit Care Med"},{"key":"5_CR186","doi-asserted-by":"publisher","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","volume":"296","author":"R Sartori","year":"2009","unstructured":"Sartori R, Milan G, Patron M et al (2009) Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296:C1248\u2013C1257","journal-title":"Am J Physiol Cell Physiol"},{"key":"5_CR187","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/ng.2772","volume":"45","author":"R Sartori","year":"2013","unstructured":"Sartori R, Schirwis E, Blaauw B et al (2013) BMP signaling controls muscle mass. Nat Genet 45:1309\u20131318","journal-title":"Nat Genet"},{"key":"5_CR188","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1210\/en.2008-0259","volume":"149","author":"AL Schneyer","year":"2008","unstructured":"Schneyer AL, Sidis Y, Gulati A et al (2008) Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology 149:4589\u20134595","journal-title":"Endocrinology"},{"key":"5_CR189","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/bjc.1996.294","volume":"73","author":"HR Scott","year":"1996","unstructured":"Scott HR, Mcmillan DC, Crilly A et al (1996) The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer 73:1560\u20131562","journal-title":"Br J Cancer"},{"key":"5_CR190","doi-asserted-by":"publisher","first-page":"13874","DOI":"10.1074\/jbc.M707820200","volume":"283","author":"G Sengle","year":"2008","unstructured":"Sengle G, Charbonneau NL, Ono RN et al (2008a) Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 283:13874\u201313888","journal-title":"J Biol Chem"},{"key":"5_CR191","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jmb.2008.06.074","volume":"381","author":"G Sengle","year":"2008","unstructured":"Sengle G, Ono RN, Lyons KM et al (2008b) A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J Mol Biol 381:1025\u20131039","journal-title":"J Mol Biol"},{"key":"5_CR192","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1016\/j.yexcr.2010.05.035","volume":"316","author":"AL Serrano","year":"2010","unstructured":"Serrano AL, Munoz-Canoves P (2010) Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 316:3050\u20133058","journal-title":"Exp Cell Res"},{"key":"5_CR193","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/micr.20392","volume":"27","author":"CX Shao","year":"2007","unstructured":"Shao CX, Liu M, Wu X et al (2007) Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection. Microsurgery 27:487\u2013493","journal-title":"Microsurgery"},{"key":"5_CR194","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685\u2013700","journal-title":"Cell"},{"key":"5_CR195","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1006\/dbio.2000.9802","volume":"224","author":"YQ Shi","year":"2000","unstructured":"Shi YQ, Katsev S, Cai C et al (2000) BMP signaling is required for heart formation in vertebrates. Dev Biol 224:226\u2013237","journal-title":"Dev Biol"},{"key":"5_CR196","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/er.2003-0007","volume":"25","author":"S Shimasaki","year":"2004","unstructured":"Shimasaki S, Moore RK, Otsuka F et al (2004) The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25:72\u2013101","journal-title":"Endocr Rev"},{"key":"5_CR197","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525\u2013527","journal-title":"Nat Genet"},{"key":"5_CR198","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/513906","volume":"61","author":"CL Shovlin","year":"1997","unstructured":"Shovlin CL, Hughes JM, Scott J et al (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61:68\u201379","journal-title":"Am J Hum Genet"},{"key":"5_CR199","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1210\/en.2006-0089","volume":"147","author":"Y Sidis","year":"2006","unstructured":"Sidis Y, Mukherjee A, Keutmann H et al (2006) Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 147:3586\u20133597","journal-title":"Endocrinology"},{"key":"5_CR200","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1210\/en.2011-1632","volume":"153","author":"CM Simpson","year":"2012","unstructured":"Simpson CM, Stanton PG, Walton KL et al (2012) Activation of latent human GDF9 by a single residue change (Gly 391 Arg) in the mature domain. Endocrinology 153:1301\u20131310","journal-title":"Endocrinology"},{"key":"5_CR201","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1597\/1545-1569(2003)040<0274:GASOCL>2.0.CO;2","volume":"40","author":"RL Slayton","year":"2003","unstructured":"Slayton RL, Williams L, Murray JC et al (2003) Genetic association studies of cleft lip and\/or palate with hypodontia outside the cleft region. Cleft Palate Craniofac J 40:274\u2013279","journal-title":"Cleft Palate Craniofac J"},{"key":"5_CR202","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1074248410381757","volume":"16","author":"CF Spurney","year":"2011","unstructured":"Spurney CF, Sali A, Guerron AD et al (2011) Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient Mdx mice. J Cardiovasc Pharmacol Ther 16:87\u201395","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"5_CR203","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","volume":"11","author":"BH Tan","year":"2008","unstructured":"Tan BH, Fearon KC (2008) Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 11:400\u2013407","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"5_CR204","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/cs0990105","volume":"99","author":"A Tanabe","year":"2000","unstructured":"Tanabe A, Taketani S, Endo-Ichikawa Y et al (2000) Analysis of the candidate genes responsible for non-syndromic cleft lip and palate in Japanese people. Clin Sci 99:105\u2013111","journal-title":"Clin Sci"},{"key":"5_CR205","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00126334-200210010-00014","volume":"31","author":"AM Tang","year":"2002","unstructured":"Tang AM, Forrester J, Spiegelman D et al (2002) Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31:230\u2013236","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5_CR206","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P Dijke Ten","year":"2007","unstructured":"Ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857\u2013869","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5_CR207","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1227\/01.NEU.0000363722.42097.C2","volume":"66","author":"JP Thawani","year":"2010","unstructured":"Thawani JP, Wang AC, Than KD et al (2010) Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery 66:233\u2013246, discussion 246","journal-title":"Neurosurgery"},{"key":"5_CR208","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1097-0142(197905)43:5+<2004::AID-CNCR2820430708>3.0.CO;2-#","volume":"43","author":"A Theologides","year":"1979","unstructured":"Theologides A (1979) Cancer cachexia. Cancer 43:2004\u20132012","journal-title":"Cancer"},{"key":"5_CR209","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ng0796-343","volume":"13","author":"S Thiagalingam","year":"1996","unstructured":"Thiagalingam S, Lengauer C, Leach FS et al (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343\u2013346","journal-title":"Nat Genet"},{"key":"5_CR210","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/08977190109029114","volume":"18","author":"RS Thies","year":"2001","unstructured":"Thies RS, Chen T, Davies MV et al (2001) GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18:251\u2013259","journal-title":"Growth Factors"},{"key":"5_CR211","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ng0396-315","volume":"12","author":"JT Thomas","year":"1996","unstructured":"Thomas JT, Lin K, Nandedkar M et al (1996) A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 12:315\u2013317","journal-title":"Nat Genet"},{"key":"5_CR212","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/ng0997-58","volume":"17","author":"JT Thomas","year":"1997","unstructured":"Thomas JT, Kilpatrick MW, Lin K et al (1997) Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58\u201364","journal-title":"Nat Genet"},{"key":"5_CR213","doi-asserted-by":"publisher","first-page":"40235","DOI":"10.1074\/jbc.M004356200","volume":"275","author":"M Thomas","year":"2000","unstructured":"Thomas M, Langley B, Berry C et al (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275:40235\u201340243","journal-title":"J Biol Chem"},{"key":"5_CR214","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/hmg\/ddm150","volume":"16","author":"M Thys","year":"2007","unstructured":"Thys M, Schrauwen I, Vanderstraeten K et al (2007) The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations. Hum Mol Genet 16:2021\u20132030","journal-title":"Hum Mol Genet"},{"key":"5_CR215","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrc927","volume":"2","author":"MJ Tisdale","year":"2002","unstructured":"Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2:862\u2013871","journal-title":"Nat Rev Cancer"},{"key":"5_CR216","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89:381\u2013410","journal-title":"Physiol Rev"},{"key":"5_CR217","doi-asserted-by":"publisher","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","volume":"296","author":"AU Trendelenburg","year":"2009","unstructured":"Trendelenburg AU, Meyer A, Rohner D et al (2009) Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296:C1258\u2013C1270","journal-title":"Am J Physiol Cell Physiol"},{"key":"5_CR218","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1517\/14712598.6.2.147","volume":"6","author":"K Tsuchida","year":"2006","unstructured":"Tsuchida K (2006) The role of myostatin and bone morphogenetic proteins in muscular disorders. Expert Opin Biol Ther 6:147\u2013154","journal-title":"Expert Opin Biol Ther"},{"key":"5_CR219","doi-asserted-by":"publisher","first-page":"40788","DOI":"10.1074\/jbc.M006114200","volume":"275","author":"K Tsuchida","year":"2000","unstructured":"Tsuchida K, Arai KY, Kuramoto Y et al (2000) Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 275:40788\u201340796","journal-title":"J Biol Chem"},{"key":"5_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2004.02.006","volume":"225","author":"K Tsuchida","year":"2004","unstructured":"Tsuchida K, Nakatani M, Matsuzaki T et al (2004) Novel factors in regulation of activin signaling. Mol Cell Endocrinol 225:1\u20138","journal-title":"Mol Cell Endocrinol"},{"key":"5_CR221","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ceb.2007.09.005","volume":"19","author":"I Vakonakis","year":"2007","unstructured":"Vakonakis I, Campbell ID (2007) Extracellular matrix: from atomic resolution to ultrastructure. Curr Opin Cell Biol 19:578\u2013583","journal-title":"Curr Opin Cell Biol"},{"key":"5_CR222","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/mt.2013.186","volume":"21","author":"D Vallese","year":"2013","unstructured":"Vallese D, Negroni E, Duguez S et al (2013) The Rag2(-)Il2rb(-)Dmd(-) mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies. Mol Ther 21:1950\u20131957","journal-title":"Mol Ther"},{"key":"5_CR223","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/sj.onc.1202118","volume":"17","author":"A Villanueva","year":"1998","unstructured":"Villanueva A, Garcia C, Paules AB et al (1998) Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. Oncogene 17:1969\u20131978","journal-title":"Oncogene"},{"issue":"3","key":"5_CR224","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.gtc.2009.06.009","volume":"38","author":"Renuka Visvanathan","year":"2009","unstructured":"Visvanathan R, Chapman IM (2009) Undernutrition and anorexia in the older person. Gastroenterol Clin North Am 38:39\u2013409","journal-title":"Gastroenterology Clinics of North America"},{"key":"5_CR225","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1073\/pnas.0408729102","volume":"102","author":"KR Wagner","year":"2005","unstructured":"Wagner KR, Liu X, Chang X et al (2005) Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A 102:2519\u20132524","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR226","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/apha.12190","volume":"210","author":"BT Wall","year":"2014","unstructured":"Wall BT, Dirks ML, Snijders T et al (2014) Substantial skeletal muscle loss occurs during only 5 days of disuse. Acta Physiol (Oxf) 210:600\u2013611","journal-title":"Acta Physiol (Oxf)"},{"key":"5_CR227","doi-asserted-by":"publisher","first-page":"9311","DOI":"10.1074\/jbc.M808763200","volume":"284","author":"KL Walton","year":"2009","unstructured":"Walton KL, Makanji Y, Wilce MC et al (2009) A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands. J Biol Chem 284:9311\u20139320","journal-title":"J Biol Chem"},{"key":"5_CR228","doi-asserted-by":"crossref","unstructured":"Walton KL, Makanji Y, Chen J et al. (2010) Two distinct regions of latency associated peptide coordinate stability of the latent TGF-{beta}1 complex. J Biol Chem 285(22):17029\u201317037","DOI":"10.1074\/jbc.M110.110288"},{"key":"5_CR229","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mus.21573","volume":"41","author":"KI Watt","year":"2010","unstructured":"Watt KI, Jaspers RT, Atherton P et al (2010) SB431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force. Muscle Nerve 41:624\u2013629","journal-title":"Muscle Nerve"},{"key":"5_CR230","doi-asserted-by":"crossref","first-page":"C1069","DOI":"10.1152\/ajpcell.1999.276.5.C1069","volume":"276","author":"MT Wheeler","year":"1999","unstructured":"Wheeler MT, Snyder EC, Patterson MN et al (1999) An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle. Am J Physiol 276:C1069\u2013C1078","journal-title":"Am J Physiol"},{"key":"5_CR231","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/bjc.1997.17","volume":"75","author":"SJ Wigmore","year":"1997","unstructured":"Wigmore SJ, Plester CE, Richardson RA et al (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75:106\u2013109","journal-title":"Br J Cancer"},{"key":"5_CR232","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gut.49.3.409","volume":"49","author":"S Wildi","year":"2001","unstructured":"Wildi S, Kleeff J, Maruyama H et al (2001) Overexpression of activin A in stage IV colorectal cancer. Gut 49:409\u2013417","journal-title":"Gut"},{"key":"5_CR233","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1083\/jcb.201109091","volume":"197","author":"CE Winbanks","year":"2012","unstructured":"Winbanks CE, Weeks KL, Thomson RE et al (2012) Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J Cell Biol 197:997\u20131008","journal-title":"J Cell Biol"},{"key":"5_CR234","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1083\/jcb.201211134","volume":"203","author":"CE Winbanks","year":"2013","unstructured":"Winbanks CE, Chen JL, Qian H et al (2013) The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol 203:345\u2013357","journal-title":"J Cell Biol"},{"key":"5_CR235","doi-asserted-by":"publisher","first-page":"15842","DOI":"10.1073\/pnas.2534946100","volume":"100","author":"NM Wolfman","year":"2003","unstructured":"Wolfman NM, Mcpherron AC, Pappano WN et al (2003) Activation of latent myostatin by the BMP-1\/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A 100:15842\u201315846","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR236","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/cr.2008.327","volume":"19","author":"KH Wrighton","year":"2009","unstructured":"Wrighton KH, Lin X, Feng XH (2009a) Phospho-control of TGF-beta superfamily signaling. Cell Res 19:8\u201320","journal-title":"Cell Res"},{"key":"5_CR237","doi-asserted-by":"publisher","first-page":"9755","DOI":"10.1074\/jbc.M809223200","volume":"284","author":"KH Wrighton","year":"2009","unstructured":"Wrighton KH, Lin X, Yu PB et al (2009b) Transforming growth factor {beta} Can stimulate Smad1 phosphorylation independently of bone morphogenic protein receptors. J Biol Chem 284:9755\u20139763","journal-title":"J Biol Chem"},{"key":"5_CR238","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","volume":"16","author":"MY Wu","year":"2009","unstructured":"Wu MY, Hill CS (2009) Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16:329\u2013343","journal-title":"Dev Cell"},{"key":"5_CR239","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ajpath.2013.12.029","volume":"184","author":"BC Yaden","year":"2014","unstructured":"Yaden BC, Wang YX, Wilson JM et al (2014) Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice. Am J Pathol 184:1152\u20131166","journal-title":"Am J Pathol"},{"key":"5_CR240","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1359\/jbmr.1998.13.10.1569","volume":"13","author":"Y Yamada","year":"1998","unstructured":"Yamada Y, Miyauchi A, Goto J et al (1998) Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13:1569\u20131576","journal-title":"J Bone Miner Res"},{"key":"5_CR241","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00441-009-0889-4","volume":"339","author":"S Zanotti","year":"2010","unstructured":"Zanotti S, Gibertini S, Mora M (2010) Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta 1 treatment. Cell Tissue Res 339:397\u2013410","journal-title":"Cell Tissue Res"},{"key":"5_CR242","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.930582","volume":"54","author":"J Zdychova","year":"2005","unstructured":"Zdychova J, Komers R (2005) Emerging role of Akt kinase\/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res 54:1\u201316","journal-title":"Physiol Res"},{"key":"5_CR243","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1242\/dev.122.10.2977","volume":"122","author":"H Zhang","year":"1996","unstructured":"Zhang H, Bradley A (1996) Mice deficient for BMP2 are nonviable and have defects in amnion\/chorion and cardiac development. Development 122:2977\u20132986","journal-title":"Development"},{"key":"5_CR244","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10974-005-9050-5","volume":"27","author":"DL Zhang","year":"2006","unstructured":"Zhang DL, Liu M, Ding F et al (2006) Expression of myostatin RNA transcript and protein in gastrocnemius muscle of rats after sciatic nerve resection. J Muscle Res Cell Motil 27:37\u201344","journal-title":"J Muscle Res Cell Motil"},{"key":"5_CR245","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s12013-014-0023-4","volume":"70","author":"P Zhang","year":"2014","unstructured":"Zhang P, Li WJ, Liu HJ et al (2014) Dystrophin involved in the susceptibility of slow muscles to hindlimb unloading via concomitant activation of TGF-beta 1\/Smad3 signaling and ubiquitin-proteasome degradation in mice. Cell Biochem Biophys 70:1057\u20131067","journal-title":"Cell Biochem Biophys"},{"key":"5_CR246","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","volume":"6","author":"J Zhao","year":"2007","unstructured":"Zhao J, Brault JJ, Schild A et al (2007) FoxO3 coordinately activates protein degradation by the autophagic\/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6:472\u2013483","journal-title":"Cell Metab"},{"key":"5_CR247","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1086\/323703","volume":"69","author":"XP Zhou","year":"2001","unstructured":"Zhou XP, Woodford-Richens K, Lehtonen R et al (2001) Germline mutations in BMPR1A\/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 69:704\u2013711","journal-title":"Am J Hum Genet"},{"key":"5_CR248","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J et al (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142:531\u2013543","journal-title":"Cell"},{"key":"5_CR249","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cyto.2004.03.007","volume":"26","author":"X Zhu","year":"2004","unstructured":"Zhu X, Topouzis S, Liang LF et al (2004) Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26:262\u2013272","journal-title":"Cytokine"},{"key":"5_CR250","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1126\/science.1069525","volume":"296","author":"TA Zimmers","year":"2002","unstructured":"Zimmers TA, Davies MV, Koniaris LG et al (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296:1486\u20131488","journal-title":"Science"},{"key":"5_CR251","first-page":"3590","volume":"51","author":"G Zugmaier","year":"1991","unstructured":"Zugmaier G, Paik S, Wilding G et al (1991) Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 51:3590\u20133594","journal-title":"Cancer Res"}],"container-title":["Advances in Experimental Medicine and Biology","Growth Factors and Cytokines in Skeletal Muscle Development, Growth, Regeneration and Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-27511-6_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T19:01:31Z","timestamp":1655319691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-27511-6_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319275093","9783319275116"],"references-count":251,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-27511-6_5","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-27511-6","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}